ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "The EPIC-CAD Trial"
Episode Synopsis
Gi-Byoung Nam, Duk-Woo Park, and C. Michael Gibson weigh edoxaban monotherapy vs dual antithrombotic therapy for patients with AF and stable coronary artery disease.
More episodes of the podcast Talking Points
The CLEAR SYNERGY (OASIS 9) Trial
17/09/2025
The NOTION-3 Trial
03/09/2025
TMVR in the Heart Failure Paradigm
15/08/2025
The ABYSS Trial
13/08/2025
Patient Selection and Treatment Goals
11/08/2025
Women's Health Study: Biomarkers
06/08/2025
Echocardiography and Quality Data
04/08/2025
Insights on Intrepid 2-Yr Mitral TF EFS
30/07/2025
New ESC Guidelines for AF
23/07/2025
The STEEER-AF Trial
09/07/2025
In God we trust